Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report

Pembrolizumab is an immune checkpoint inhibitor (ICI) that targets programmed death-1. Although ICIs have shown efficacy in the treatment of lung cancer, they have also been reported to cause a variety of immune-related adverse events (irAEs). Hepatotoxicity is a known irAEs, but currently, there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Anna, Nakamichi, Shinji, Nakayama, Yukako, Nagano, Atsuhiro, Mikami, Erika, Takano, Natsuki, Tozuka, Takehiro, Matsumoto, Masaru, Miyanaga, Akihiko, Noro, Rintaro, Terasaki, Yasuhiro, Kubota, Kaoru, Seike, Masahiro, Gemma, Akihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188365/
https://www.ncbi.nlm.nih.gov/pubmed/35698605
http://dx.doi.org/10.2147/OTT.S361467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188365/
https://www.ncbi.nlm.nih.gov/pubmed/35698605
http://dx.doi.org/10.2147/OTT.S361467

Ejemplares similares